1. Home
  2. MNDR vs ENSC Comparison

MNDR vs ENSC Comparison

Compare MNDR & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNDR
  • ENSC
  • Stock Information
  • Founded
  • MNDR 2016
  • ENSC 2003
  • Country
  • MNDR Singapore
  • ENSC United States
  • Employees
  • MNDR N/A
  • ENSC N/A
  • Industry
  • MNDR
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MNDR
  • ENSC Health Care
  • Exchange
  • MNDR Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • MNDR 6.8M
  • ENSC 6.4M
  • IPO Year
  • MNDR 2024
  • ENSC N/A
  • Fundamental
  • Price
  • MNDR $0.76
  • ENSC $2.07
  • Analyst Decision
  • MNDR
  • ENSC
  • Analyst Count
  • MNDR 0
  • ENSC 0
  • Target Price
  • MNDR N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • MNDR 706.3K
  • ENSC 58.1K
  • Earning Date
  • MNDR 10-28-2025
  • ENSC 11-11-2025
  • Dividend Yield
  • MNDR N/A
  • ENSC N/A
  • EPS Growth
  • MNDR N/A
  • ENSC N/A
  • EPS
  • MNDR N/A
  • ENSC N/A
  • Revenue
  • MNDR $11,600,567.00
  • ENSC $7,413,722.00
  • Revenue This Year
  • MNDR $188,831.77
  • ENSC N/A
  • Revenue Next Year
  • MNDR $76.44
  • ENSC $1,354.55
  • P/E Ratio
  • MNDR N/A
  • ENSC N/A
  • Revenue Growth
  • MNDR 0.61
  • ENSC 415.58
  • 52 Week Low
  • MNDR $0.73
  • ENSC $1.62
  • 52 Week High
  • MNDR $8.00
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • MNDR 34.66
  • ENSC 45.19
  • Support Level
  • MNDR $0.74
  • ENSC $2.02
  • Resistance Level
  • MNDR $0.93
  • ENSC $2.19
  • Average True Range (ATR)
  • MNDR 0.07
  • ENSC 0.10
  • MACD
  • MNDR -0.02
  • ENSC 0.00
  • Stochastic Oscillator
  • MNDR 8.04
  • ENSC 25.91

About MNDR Mobile-health Network Solutions Class A Ordinary Shares

Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: